Collegium Pharmaceutical, Inc.
COLLCollegium Pharmaceutical is a diversified biopharmaceutical company focused on developing and commercializing differentiated products for serious medical conditions, specifically in the areas of pain management and neuropsychiatry.
Earnings
Next report
Nov 5, 2026 (in 2 months)Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Collegium Pharmaceutical is a diversified biopharmaceutical company focused on developing and commercializing differentiated products for serious medical conditions, specifically in the areas of pain management and neuropsychiatry. The company leverages proprietary technology platforms and strategic acquisitions to provide treatments for moderate to severe pain and attention deficit hyperactivity disorder (ADHD). Its core value proposition centers on offering abuse-deterrent formulations and unique dosing schedules to improve patient outcomes and safety.
A leading player in the abuse-deterrent opioid market with a growing presence in the ADHD stimulant market through differentiated delivery technologies.
FAQ
- What is Collegium Pharmaceutical, Inc.'s market cap?
- Collegium Pharmaceutical, Inc. (COLL) has a market capitalization of $722.4M and trades on NASDAQ.
- What is Collegium Pharmaceutical, Inc.'s revenue and profitability?
- Collegium Pharmaceutical, Inc. generated $808.2M in trailing twelve-month revenue with net income of $47.9M, representing a net margin of 5.9%. Gross margin stands at 60.0%, with free cash flow of $328.3M. The latest reported period is Q2 2026.
- Who are Collegium Pharmaceutical, Inc.'s competitors?
- Collegium Pharmaceutical, Inc.'s key competitors include Indivior, Ensysce Biosciences, Inc. Common Stock, Dogwood Therapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Collegium Pharmaceutical, Inc. partner with?
- Collegium Pharmaceutical, Inc.'s notable partners include Hikma Pharmaceuticals USA Inc., RADARS System, Inflexxion.
- What subsidiaries does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc.'s subsidiaries include Ironshore Therapeutics.
- Where is Collegium Pharmaceutical, Inc. headquartered?
- Collegium Pharmaceutical, Inc. is headquartered in United States of America and employs approximately 197 people. It has been publicly traded since 2015.
